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First described together in 1988, S. lug-
dunensis and S. schleiferi are coagulase-
negative Staphylococcus (CNS) species
that recently have emerged as potential
zoonotic pathogens (Freney et al., 1988).
S. lugdunensis typically has been associated
with human disease, primarily skin infec-
tions and endocarditis, but recently also
has been described as an animal pathogen
(Frank et al., 2008; Rook et al., 2012).
S. schleiferi, which may be coagulase neg-
ative (CNS: subsp. schleiferi) or coagulase
positive (CPS: subsp. coagulans), typically
has been associated with skin infections
in dogs and cats, but recently has been
described as a human pathogen (Kumar
et al., 2007; Tzamalis et al., 2013). In this
sense, we apply Calvin Schwabe’s defini-
tion of zoonosis as “shared infection” of
animals and man, without ascribing direc-
tion of transmission from one to the other
(Schwabe, 1984).
While the ubiquitous nature of the
genus Staphylococcus generally, and CNS
specifically, enhances opportunities for
infection, the genetic characteristics of
S. lugdunensis and S. schleiferi make them
worthy of closer scrutiny. Both of these
pathogens historically have been con-
sidered opportunistic and susceptible to
many antimicrobials, unlike methicillin-
resistant S. aureus (MRSA) and the
veterinary pathogen methicillin-resistant
S. pseudintermedius (MRSP), for which
multidrug resistance is an ongoing clini-
cal concern. Both S. schleiferi and S. lug-
dunensis have been demonstrated to carry
SCCmec elements, and S. schleiferi isolates
have been identified recently as multidrug
resistant (Roberts et al., 2005; Starlander
et al., 2011; Cain, 2013; Penna et al.,
2013). S. lugdunensis and S. schleiferi
are examples of CNS often overlooked
by routine clinical diagnostic protocols
that may be emerging as drug-resistant
pathogens.
S. schleiferi is divided into two
subspecies, subsp. schleiferi (coagulase-
negative) and subsp. coagulans (coagulase-
positive), which behave similarly in
animals (Cain, 2013). They typically cause
otitis or pyoderma in dogs, and rarely may
be isolated from cats or birds (Abraham
et al., 2007; Briscoe et al., 2009; Cain,
2013). Prevalence from skin, nares, mouth,
or perineal carriage in the absence of dis-
ease is low, typically ≤2%, but is higher
among diseased pets (Abraham et al.,
2007; Griffeth et al., 2008; Beck et al.,
2012; May et al., 2012). Of concern is
the propensity for clinical isolates to be
methicillin resistant, with many veteri-
nary studies in the last decade reporting
rates of 50% or higher (Kania et al., 2004;
Bemis et al., 2006; Vanni et al., 2009; Cain
et al., 2011a,b; Penna et al., 2013). SCCmec
IV has been described in clinical isolates
of S. schleiferi subsp. coagulans from pets
(Roberts et al., 2005). Among methicillin-
resistant isolates, decreased susceptibility
to erythromycin or fluoroquinolones has
been observed (Intorre et al., 2007; Vanni
et al., 2009; Cain et al., 2011b). One
of these studies linked fluoroquinolone
resistance to alterations in the gyrA gene
(Intorre et al., 2007). Our experience at
the Veterinary Hospital at the University
of Pennsylvania suggests that a trend of
increasing resistance may be occurring. In
2012, 14% of all S. schleiferi isolates from
our microbiology laboratory were resis-
tant to erythromycin, an increase from 9%
in 2005; 16% of isolates were resistant to
tetracycline, an increase from 6% in 2005;
and notably, 14% of isolates were resis-
tant to trimethoprim-sulfamethoxazole,
while no resistance was observed in
2005 (Rankin unpublished data). These
data suggest that increasing antimi-
crobial resistance is limiting treatment
options for clinical S. schleiferi infections
in animals.
Little attention has been paid to
S. schleiferi in people outside of reports
of outbreaks or individual cases (Freney
et al., 1988; Vandenesch et al., 1994;
Kluytmans et al., 1998; Hernandez et al.,
2001; Kumar et al., 2007; Tzamalis et al.,
2013). Although some reports have
focused on surgical site infections, includ-
ing those associated with pacemakers,
others demonstrate a wider variety of
sources, including wound or eye infections
and meningitis (Hernandez et al., 2001;
Tzamalis et al., 2013). Asymptomatic nasal
or skin carriage in people with veteri-
nary occupational contact also has been
demonstrated, but prevalence may be
≤2% (Ishihara et al., 2010; Morris et al.,
2010).
A paucity of data regarding genetic
characterization of S. schleiferi limits dis-
cussion of its virulence. Genetically, CNS
and CPS subspecies appear similar by
pulsed-field gel electrophoresis (PFGE),
particularly within methicillin-resistant
strains (Yamashita et al., 2005; Cain et al.,
2011a). Human outbreak isolates also have
been found to be concordant by PFGE
(Kluytmans et al., 1998). While these data
suggest that the species may have low
diversity, an insufficient number of strains
have been typed globally to be conclusive.
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At the time of writing, the genome has yet
to be sequenced. Like S. aureus, S. schleiferi
may produce beta-hemolysin and exoen-
zymes, such as lipase, potentially associ-
ated with virulence (Hebert, 1990; Lambe
et al., 1990; Linehan et al., 1992; Yamashita
et al., 2005). It also shows adherence to
glass, which may be relevant as a marker
of propensity for infection of indwelling
devices (Hebert, 1990). A murine model
demonstrated that both S. schleiferi and
S. lugdunensis formed abscesses at rates
of 75–100%, similar to S. epidermidis but
more frequent than S. warneri or S. homi-
nis (all of which are CNS) (Lambe et al.,
1990).
In contrast to S. schleiferi, S. lugdunensis
primarily has been described as a human
pathogen. Inguinal skin carriage is typ-
ical in people, as are skin infections in
the groin, pelvic girdle or perineum (van
der Mee-Marquet et al., 2003; Frank et al.,
2008). Cardiovascular infections are com-
mon, with a 40% case-fatality rate among
those reported in the literature, and S. lug-
dunensis also has been described in infec-
tions of the bone, joint, central nervous
system, eye, and other sites (Frank et al.,
2008).
Unlike S. schleiferi, S. lugdunensis
tends to exhibit broad susceptibility to
antimicrobial drugs, but may produce
beta-lactamases (Hellbacher et al., 2006;
Frank et al., 2008). One study of five clin-
ical isolates in China noted that 80% of
them produced beta-lactamase that all
beta-lactamase-producing isolates demon-
strated additional antimicrobial resistance
phenotypes, and that 60% of isolates car-
ried the ermC gene and were resistant
to erythromycin (Liu et al., 2012). A few
reports describe the occurrence of mecA
in S. lugdunensis, including one report
identifying the SCCmec type as V, similar
to some community-associated S. aureus
(Frank et al., 2008; Pereira et al., 2011;
Liu et al., 2012). In addition, a novel
penicillin binding protein mutation in
a mecA-negative, beta-lactamase-resistant
isolate has been described (Kotsakis et al.,
2011). Laboratory discrepancies between
presence ofmecA and oxacillin disc testing
may limit the reliability of disc methods
(Ferreira et al., 2003). Development of
resistance following antimicrobial treat-
ment was described in a case report, but
the frequency of acquisition of mobile
genetic elements that confer resistance is
unknown for S. lugdunensis (Kragsbjerg
et al., 2000). Of note, many S. lugdunen-
sis clinical isolates have demonstrated
tolerance to vancomycin and related
glycopeptides, although the isolates’ typ-
ical susceptibility to other classes of
antimicrobials eases current therapeutic
concerns (Frank et al., 2008). Ongoing
surveillance for acquisition of multidrug
resistance characteristics by vancomycin
tolerant clones of S. lugdunensis is
important in clinical settings.
In animals, a number of case reports
and a recent case-control study demon-
strate a variety of infections in pets,
predominantly dogs but also cats, birds,
and small mammalian “pocket” pets
(Briscoe et al., 2009; Beck et al., 2012;
Nakamura et al., 2012; Rook et al., 2012).
One of these case reports described a
methicillin-resistant S. lugdunensis (mecA
gene not tested) isolated from a dog that
died of vegetative endocarditis (Nakamura
et al., 2012). In the case-control study,
S. lugdunensis cases were compared to
S. pseudintermedius controls, and cases
demonstrated associations with respira-
tory or skin infections, in-patient status,
and prior use of steroids (Rook et al.,
2012). S. lugdunensis also has been iso-
lated from carriage sites in healthy ani-
mals (Kasprowicz et al., 2011; Beck et al.,
2012). Like S. aureus, S. lugdunensis has
been observed in food-producing animals
(specifically sheep and goats), but the fre-
quency of such occurrence is unknown
(Deinhofer and Pernthaner, 1995; Zhang
et al., 2009).
S. lugdunensis appears to be geneti-
cally conserved (Hellbacher et al., 2006;
Frank et al., 2008; Chassain et al., 2012;
Liu et al., 2012). Both S. schleiferi and
S. lugdunensis have been shown to pro-
duce toxin genes, including staphylococ-
cal enterotoxins (SEs) and toxic shock
syndrome toxin (Udo et al., 1999; de
Oliveira Calsolari et al., 2011). However,
the prevalences for and origins of SE or
TSST within these CNS species are largely
unknown. The accessory gene regulator
(agr) locus, responsible for regulation of
SE and other virulence factors, is similar
in S. lugdunensis, S. aureus, and veterinary
pathogen S. (pseud-)intermedius (Frank
et al., 2008). Homology between cadmium
resistance genes cadD and cadX carried
by S. aureus and S. lugdunensis suggests a
genetic transfer event from S. lugdunen-
sis plasmid pLUG10 to S. aureus plasmid
pRW001 (Frank et al., 2008). Although
the clinical importance of this particu-
lar transfer is unclear, it demonstrates
the potential for horizontal gene transfer
between these bacterial species.
The genome of S. lugdunensis has been
sequenced twice, demonstrating a 78%
homology with S. aureus, but no plasmids
were identified in the two isolates, which
were selected from human cases of skin
infection (Tse et al., 2010; Heilbronner
et al., 2011). The lack of plasmids may
be due to the presence of a CRISPR
region in the N920143 isolate genome,
shared with S. epidermidis and associated
with low rates of horizontal gene trans-
fer (Heilbronner et al., 2011). However,
N920143 was archived in the early 1990s
and may not represent the current sta-
tus of S. lugdunensis isolates responsible
for clinical infections; for example, it con-
tained no enterotoxin genes (Heilbronner
et al., 2011). S. lugdunensis is distinct
from other staphylococci in production
of non-ribosomal protein synthetases and
unusual surface proteins, although the
effects of these characteristics on virulence
are unknown (Heilbronner et al., 2011).
Genomic comparison between S. lug-
dunensis and other sequenced genomes
of Staphylococcus revealed presence of an
isd iron uptake locus also linked to viru-
lence, as well as genes responsible for pro-
ducing sphingomyelinase beta-toxin (hlb)
and haemolysin III, similar to S. aureus
(Heilbronner et al., 2011). Studies per-
formed prior to genomic sequencing sup-
port the ability of S. lugdunensis to produce
a delta-hemolysin and to form biofilms
(Frank et al., 2008). Genetic results sug-
gest both new and conserved mechanisms
of virulence within S. lugdunensis inde-
pendent of its relatively low burden of
antimicrobial resistance.
While CNS typically have been con-
sidered to be less pathogenic than
CPS, virulence traits and demonstrated
pathogenicity for S. schleiferi and S. lug-
dunensis deserve concern. Laboratory
methods, particularly those based on
phenotypic characteristics, may fail to
differentiate these species from each other
and from S. aureus, and at least one mis-
take in identification has been reported
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(Pereira et al., 2011). S. schleiferi and
S. lugdunensis may resemble S. aureus
in colony morphology on blood agar,
and S. lugdunensis may possess simi-
lar biochemical characteristics, e.g. a
positive clumping factor test (bound
coagulase) that can produce erroneous
speciation results by latex agglutina-
tion (Frank et al., 2008; Pereira et al.,
2010). Additionally S. schleiferi subsp.
coagulans is positive by tube coagulase
testing, similar to S. aureus. Unlike
S. aureus, both S. schleiferi and S. lug-
dunensis lack protein A (Vandenesch et al.,
1994; Frank et al., 2008). Multiplex PCR
using primers for species-specific nuclease
(nuc) genes can differentiate S. lugdunen-
sis and S. schleiferi from each other and
from both S. aureus and S. pseudinter-
medius (Sasaki et al., 2010; Hirotaki et al.,
2011). However, automated systems for
clinical laboratory analysis may differ
in their ability to identify these species
correctly.
Clinical microbiologists are uniquely
positioned to conduct surveillance for
potentially zoonotic CNS pathogens.
While high-risk samples from people, such
as blood cultures, may be screened for
CNS, the same attention may not be given
to samples from diseased skin. Particularly
in research hospital settings, laboratory
testing for antimicrobial resistance pat-
terns, includingmecA testing and SCCmec
typing where appropriate, is important to
monitor CNS for changes in susceptibility
that may impact the response to therapy.
In particular, co-colonization by CNS and
CPS (such as S. aureus and S. pseudin-
termedius) should be noted due to the
potential for horizontal gene transfer.
Harmonized surveillance between clini-
cal microbiology laboratories that serve
human and animal patients is essential
for improved recognition of changing
antimicrobial susceptibility and virulence
characteristics among the CNS species that
infect both people and animals.
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